Connell, C. M., Shibata, A., Tookman, L. A., Archibald, K. M., Flak, M. B., Pirlo, K. J., . . . McNeish, I. A. (2011). Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells. American Society for Clinical Investigation.
Stile di citazione ChicagoConnell, Claire M., Atsushi Shibata, Laura A. Tookman, Kyra M. Archibald, Magdalena B. Flak, Katrina J. Pirlo, Michelle Lockley, Sally P. Wheatley, e Iain A. McNeish. Genomic DNA Damage and ATR-Chk1 Signaling Determine Oncolytic Adenoviral Efficacy in Human Ovarian Cancer Cells. American Society for Clinical Investigation, 2011.
Citazione MLAConnell, Claire M., et al. Genomic DNA Damage and ATR-Chk1 Signaling Determine Oncolytic Adenoviral Efficacy in Human Ovarian Cancer Cells. American Society for Clinical Investigation, 2011.